| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ... New England journal of medicine 353 (12), 1209-1223, 2005 | 7517 | 2005 |
| Biological insights from 108 schizophrenia-associated genetic loci C Pantelis, GN Papadimitriou, S Papiol, E Parkhomenko, MT Pato, ... Nature 511 (7510), 421-427, 2014 | 7443 | 2014 |
| Treatment of patients with schizophrenia AF Lehman, LB Dixon, TH McGlashan, AL Miller, DO Perkins American Psychiatric Association 1, 104-113, 2010 | 2247 | 2010 |
| Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to … TJ Miller, TH McGlashan, JL Rosen, K Cadenhead, J Ventura, ... Schizophrenia bulletin 29 (4), 703-715, 2003 | 1909 | 2003 |
| Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis DO Perkins, H Gu, K Boteva, JA Lieberman American journal of psychiatry 162 (10), 1785-1804, 2005 | 1723 | 2005 |
| Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America TD Cannon, K Cadenhead, B Cornblatt, SW Woods, J Addington, ... Archives of general psychiatry 65 (1), 28-37, 2008 | 1638 | 2008 |
| Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ... Archives of general psychiatry 64 (6), 633-647, 2007 | 1423 | 2007 |
| Modeling linkage disequilibrium increases accuracy of polygenic risk scores BJ Vilhjálmsson, J Yang, HK Finucane, A Gusev, S Lindström, S Ripke, ... The american journal of human genetics 97 (4), 576-592, 2015 | 1355 | 2015 |
| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1294 | 2022 |
| Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ... American Journal of Psychiatry 163 (4), 600-610, 2006 | 1256 | 2006 |
| The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis RSE Keefe, SG Silva, DO Perkins, JA Lieberman Schizophrenia bulletin 25 (2), 201-222, 1999 | 1035 | 1999 |
| Antipsychotic drug effects on brain morphology in first-episode psychosis JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ... Archives of general psychiatry 62 (4), 361-370, 2005 | 946 | 2005 |
| Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects CR Marshall, DP Howrigan, D Merico, B Thiruvahindrapuram, W Wu, ... Nature genetics 49 (1), 27-35, 2017 | 938 | 2017 |
| The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches JA Lieberman, D Perkins, A Belger, M Chakos, F Jarskog, K Boteva, ... Biological psychiatry 50 (11), 884-897, 2001 | 885 | 2001 |
| Predictors of noncompliance in patients with schizophrenia D Perkins Journal of Clinical Psychiatry 63 (12), 1121-1128, 2002 | 827 | 2002 |
| Microduplications of 16p11. 2 are associated with schizophrenia SE McCarthy, V Makarov, G Kirov, AM Addington, J McClellan, S Yoon, ... Nature genetics 41 (11), 1223-1227, 2009 | 819 | 2009 |
| Implications for the neural basis of social cognition for the study of schizophrenia AE Pinkham, DL Penn, DO Perkins, J Lieberman American Journal of Psychiatry 160 (5), 815-824, 2003 | 746 | 2003 |
| Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis TH McGlashan, RB Zipursky, D Perkins, J Addington, T Miller, SW Woods, ... American Journal of Psychiatry 163 (5), 790-799, 2006 | 733 | 2006 |
| microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder DO Perkins, CD Jeffries, LF Jarskog, JM Thomson, K Woods, ... Genome biology 8, 1-11, 2007 | 692 | 2007 |
| Barriers to employment for people with schizophrenia R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ... American Journal of Psychiatry 163 (3), 411-417, 2006 | 667 | 2006 |
Scott W. WoodsYale University School of Medicine在 yale.edu 的电子邮件经过验证
